SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Tenaya Therapeutics to participate in September investor conferences

Tenaya Therapeutics announced it will participate in upcoming September investor conferences. The company is a clinical-stage biotech focused on therapies targeting heart disease underlying causes.

TNYA

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.

Related stories